Full Grace Physical Therapy, Pc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2 Gramatan Avenue, Suite 206, Mt. Vernon, NY 10550 Phone: 914-664-1380 Fax: 914-664-1383 |
News Archive
Ipsen, a global biopharmaceutical group, today announced that its partner Roche has disclosed results of the phase III T-emerge 3 study in patients with diabetes with taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence. Taspoglutide originating from Ipsen's research is developed by Roche.
MAP Pharmaceuticals, Inc. today announced that its New Drug Application (NDA) for LEVADEX® orally inhaled migraine drug for the potential acute treatment of migraine in adults has been accepted for filing by the U.S. Food and Drug Administration (FDA), with a goal date of March 26, 2012 under the Prescription Drug User Fee Act (PDUFA).
A recent research review has concluded that home blood pressure monitors can help people keep their blood pressure in check and possibly cut down on medication – as long as patients and their doctors put those home readings to good use. For years, Omron Healthcare, Inc. has reminded Americans how important home blood pressure monitoring is when it comes to reducing their risk of a heart attack or stroke, and truly wants people to take the news to heart in 2011.
According to John Appleby, Chief Economist at the King's Fund, deaths from heart attacks and cancer in the UK are falling despite lower spending on health than in countries such as France. This, he said calls attention to the Government's claim that poor outcomes justify a £1.4 billion restructuring of the NHS that will pass control of budgets from managers to GPs. He said, "Comparing health outcomes across countries is complex and not simply down to healthcare spending, but these trends must challenge one of the government's key justifications for reforming the NHS."
› Verified 3 days ago